| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00109-004-0558-8 |
| P698 | PubMed publication ID | 15221077 |
| P2093 | author name string | Crispin R Dass | |
| P2860 | cites work | Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers | Q24547040 |
| Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 | ||
| Transfection Mediated by Gemini Surfactants: Engineered Escape from the Endosomal Compartment | Q27942686 | ||
| Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity | Q30973869 | ||
| Targeting the prostate for destruction through a vascular address | Q31037658 | ||
| Three-Dimensional Imaging of Lipid Gene-Carriers: Membrane Charge Density Controls Universal Transfection Behavior in Lamellar Cationic Liposome-DNA Complexes | Q31140822 | ||
| New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity | Q31914241 | ||
| Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model | Q32145219 | ||
| Lipoplexes and tumours. A review | Q33723073 | ||
| Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy | Q33933195 | ||
| The role of CpG motifs in immunostimulation and gene therapy | Q34079553 | ||
| Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells | Q34143913 | ||
| Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans | Q34345458 | ||
| Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations | Q34349082 | ||
| Development of non-viral vectors for systemic gene delivery | Q34482187 | ||
| Vehicles for oligonucleotide delivery to tumours | Q34518719 | ||
| Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency | Q34708368 | ||
| In vivo characteristics of cationic liposomes as delivery vectors for gene therapy | Q35012639 | ||
| LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth | Q45864062 | ||
| Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases | Q45864268 | ||
| Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway | Q45866399 | ||
| Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy | Q45867645 | ||
| Structural basis of DOTMA for its high intravenous transfection activity in mouse | Q45867845 | ||
| A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model | Q45869268 | ||
| Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis | Q45869591 | ||
| Multiple systemic expression of human interferon-beta in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex | Q45871435 | ||
| Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes | Q45872808 | ||
| Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA. | Q45874466 | ||
| Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice | Q45876907 | ||
| Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells | Q45878251 | ||
| Tissue distribution of the cytofectin component of a plasmid-DNA/cationic lipid complex following intravenous administration in mice | Q45880855 | ||
| A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. | Q45881607 | ||
| Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis | Q45881610 | ||
| Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes | Q45883836 | ||
| Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes | Q45886925 | ||
| Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy | Q45887356 | ||
| Towards gene therapy for cystic fibrosis: a clinical progress report. | Q45887490 | ||
| beta-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale | Q45887497 | ||
| The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes | Q45888099 | ||
| In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes | Q45888989 | ||
| Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice | Q46128630 | ||
| Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity | Q46149723 | ||
| Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice | Q46608114 | ||
| Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles | Q47574961 | ||
| Distribution of anionic sites on the capillary endothelium in an experimental brain tumor model | Q48113611 | ||
| Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms | Q48281974 | ||
| Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma | Q48466525 | ||
| Comparison of cell proliferation and toxicity assays using two cationic liposomes. | Q50770431 | ||
| Activation of host antitumoral responses by cationic lipid/DNA complexes. | Q53757942 | ||
| Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis | Q57416213 | ||
| Contribution of Plasmid DNA to Inflammation in the Lung after Administration of Cationic Lipid:pDNA Complexes | Q62566769 | ||
| Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung | Q64382719 | ||
| Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo | Q64382873 | ||
| Assessment of ocular irritability of liposome preparations | Q68014688 | ||
| Immunomodulatory activity of some amphiphilic compounds | Q68495260 | ||
| Surface densities of diaphragmed fenestrae and transendothelial channels in different murine capillary beds | Q69383428 | ||
| Cationic lipid binding to DNA: characterization of complex formation | Q71099257 | ||
| Morphogenesis of peritoneal metastasis in human gastric cancer | Q71470303 | ||
| Amphiphilic detergents inhibit production of IgG and IgM by human peripheral blood mononuclear cells | Q72331220 | ||
| The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo | Q73022551 | ||
| Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro | Q73031343 | ||
| Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model | Q73043079 | ||
| Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol | Q73192942 | ||
| Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung | Q73254119 | ||
| Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency | Q73807903 | ||
| Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization | Q73980732 | ||
| Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis | Q74138792 | ||
| Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery | Q74157974 | ||
| Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma | Q74321019 | ||
| Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic | Q77683561 | ||
| Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells | Q77925804 | ||
| Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously | Q78025452 | ||
| Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors | Q78598139 | ||
| A model for evaluating selective delivery of plasmid DNA to tumours via the vasculature | Q78624065 | ||
| Cellular uptake, distribution, and stability of 10-23 deoxyribozymes | Q78643453 | ||
| Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in-vivo | Q94180401 | ||
| Anti-inflammatory activity of cationic lipids | Q35026709 | ||
| Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood | Q35851436 | ||
| Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery | Q35990009 | ||
| Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction | Q36363647 | ||
| Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes | Q37094888 | ||
| A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung | Q37253992 | ||
| Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice | Q37380192 | ||
| Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components | Q38299533 | ||
| Antisense c-myc oligodeoxyribonucleotide cellular uptake | Q38327157 | ||
| Fate of cationic liposomes and their complex with oligonucleotide in vivo | Q38356723 | ||
| Trends in lipoplex physical properties dependent on cationic lipid structure, vehicle and complexation procedure do not correlate with biological activity | Q38678759 | ||
| The Cell Biology of Macrophage Activation | Q40081110 | ||
| Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial | Q40599715 | ||
| A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis | Q40603327 | ||
| Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors | Q40693497 | ||
| Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer | Q40761165 | ||
| Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo | Q40798037 | ||
| Membrane perturbation and the mechanism of lipid-mediated transfer of DNA into cells | Q40849371 | ||
| Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models | Q40874730 | ||
| Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency | Q40895637 | ||
| The role of CXC chemokines as regulators of angiogenesis | Q40953891 | ||
| Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo | Q41006981 | ||
| Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression | Q41074143 | ||
| Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells | Q41078793 | ||
| Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene | Q41105211 | ||
| Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery | Q41130823 | ||
| Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. | Q41201535 | ||
| Structural and functional analysis of cationic transfection lipids: the hydrophobic domain | Q41230888 | ||
| Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes | Q41239562 | ||
| Liposome-mediated DNA vaccination: the effect of vesicle composition | Q41630994 | ||
| Improved DNA: liposome complexes for increased systemic delivery and gene expression | Q41633695 | ||
| Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs | Q41921336 | ||
| The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer | Q41933071 | ||
| The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. | Q42031050 | ||
| Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency | Q42171792 | ||
| A survey of the binding of polycationic ferritin in several fenestrated capillary beds: indication of heterogeneity in the luminal glycocalyx of fenestral diaphragms | Q42465692 | ||
| Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma | Q42488361 | ||
| Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. | Q42804701 | ||
| A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity | Q42829410 | ||
| Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles | Q42832960 | ||
| Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector | Q43556290 | ||
| Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. | Q43640512 | ||
| Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes | Q43653658 | ||
| On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids | Q43710407 | ||
| Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice | Q43853335 | ||
| Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery | Q44038921 | ||
| Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion | Q44156203 | ||
| Synthesis of a single-tailed cationic lipid and investigation of its transfection | Q44568056 | ||
| Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes | Q44651403 | ||
| Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock | Q44931090 | ||
| Interaction of positively-charged liposomes with blood: implications for their application in vivo | Q45240698 | ||
| Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol. | Q45721971 | ||
| Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases | Q45857663 | ||
| Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor | Q45857899 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 579-591 | |
| P577 | publication date | 2004-06-23 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection | |
| P478 | volume | 82 |
| Q33263840 | Adenoviral sensors for high-content cellular analysis |
| Q39147224 | Barriers to Liposomal Gene Delivery: from Application Site to the Target |
| Q58046777 | Biocompatible cationic lipids for the formulation of liposomal DNA vectors |
| Q34072540 | Biophysical characterization of copolymer-protected gene vectors. |
| Q64249627 | Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery |
| Q36293364 | Cationic nanocarriers induce cell necrosis through impairment of Na(+)/K(+)-ATPase and cause subsequent inflammatory response. |
| Q40159983 | Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA. |
| Q37150905 | Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy. |
| Q37931159 | Countering hepatitis B virus infection using RNAi: how far are we from the clinic? |
| Q58207856 | Effect of membrane charge density on the protein corona of cationic liposomes: Interplay between cationic charge and surface area |
| Q47073144 | Efficient transfection strategy for the spatiotemporal control of gene expression in zebrafish |
| Q51057041 | Evaluation of fibrin-based gene-activated matrices for BMP2/7 plasmid codelivery in a rat nonunion model. |
| Q39950836 | Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide |
| Q37598096 | Lipidic systems for in vivo siRNA delivery |
| Q37508725 | Nanocarriers' entry into the cell: relevance to drug delivery |
| Q81239522 | Necessity is the mother of invention: an ingenious method for leukocyte-targeted delivery of siRNA in stabilized nanoparticles demonstrates a role of cyclin D1 in inflammation |
| Q38028448 | Nonviral gene therapy targeting cardiovascular system |
| Q36690285 | Optimization and delivery of plasmid DNA for vaccination |
| Q42787946 | PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation |
| Q40136636 | Phospholipid-based artificial viruses assembled by multivalent cations |
| Q40365247 | Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer |
| Q42920496 | Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells |
| Q38444246 | Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31. |
| Q36800000 | Review of the application of RNA interference technology in the pharmaceutical industry |
| Q39577781 | Role of temperature-independent lipoplex-cell membrane interactions in the efficiency boost of multicomponent lipoplexes |
| Q45862855 | Saporin as a novel suicide gene in anticancer gene therapy. |
| Q28266775 | Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target |
| Q36515486 | Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy. |
| Q33273936 | The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes |
| Q37226033 | The multiple faces of self-assembled lipidic systems |
| Q40111853 | Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia |
| Q40292767 | Ultrasound-mediated gene transfection: problems to be solved and future possibilities |
Search more.